Clinical Sciences - Metabolic Studies

144 - ASSOCIATION OF STAVUDINE WITH CAROTID INTIMA MEDIA THICKNESS IN A MULTI-CENTRE CANADIAN HIV COHORT

145 - C-REACTIVE PROTEIN, NEOPTERIN AND OTHER INFLAMMATORY BIOMARKERS IN HIV-ASSOCIATED ATHEROSCLEROSIS

146 - A RANDOMIZED PLACEBO CONTROLLED TRIAL OF ROSIGLITAZONE FOR THE TREATMENT OF HIV LIPODYSTROPHY

147 - PILOT STUDY OF THE SAFETY, CLINICAL EFFICACY AND IMPACT ON QUALITY OF LIFE OF USING BIO-ALCAMID(TM) FOR THE RECONSTRUCTIVE TREATMENT OF ANTIRETROVIRAL-INDUCED FACIAL LIPOATROPHY IN HIV-POSITIVE INDIVIDUALS

148 - KIDNEY MITOCHONDRIAL DNA LEVELS IN HIV PATIENTS WITH RENAL DYSFUNCTION ON TENOFOVIR-CONTAINING THERAPY ARE MARKEDLY REDUCED WITH CONCURRENT DIDANOSINE THERAPY

149 - BONE MINERAL DENSITY AND FRACTURE IN HIV POSITIVE CANADIAN WOMEN: RESULTS OF A MULTICENTRED CROSS-SECTIONAL CASE CONTROL STUDY

150 - VIROLOGIC EFFICACY AND LIPID PROFILES OF ATAZANAVIR (ATV)-BASED REGIMENS WITH OR WITHOUT RITONAVIR (R) BOOSTING IN TREATMENT-EXPERIENCED PATIENTS

151 - NRTI SPARING TRIAL: ANTIVIRAL AND METABOLIC EFFECTS OF NEVIRAPINE (NVP) + LOPINAVIR/RITONAVIR (LPV/R) vs ZIDOVUDINE/LAMIVUDINE (AZT/3TC) + NVP vs AZT/3TC + LPV/R (CTN 177)